Fdc Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of FDC Ltd is ₹ 364.7 as of 30 Apr 15:30 . The P/E Ratio of FDC Ltd changed from 16 on March 2021 to 24.1 on March 2025 . This represents a CAGR of 8.54% over 5 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of FDC Ltd changed from ₹ 4822 crore on March 2021 to ₹ 6419 crore on March 2025 . This represents a CAGR of 5.89% over 5 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 20003 crore on March 2025 to ₹ 20003 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of FDC Ltd for the Dec '25 is ₹ 485.51 crore as compare to the Sep '25 revenue of ₹ 493.66 crore. This represent the decline of -1.65% The revenue of OneSource Specialty Pharma Ltd for the Dec '25 is ₹ 294.97 crore as compare to the Sep '25 revenue of ₹ 378.8 crore. This represent the decline of -22.13% The ebitda of FDC Ltd for the Dec '25 is ₹ 52.29 crore as compare to the Sep '25 ebitda of ₹ 54.44 crore. This represent the decline of -3.95% The ebitda of OneSource Specialty Pharma Ltd for the Dec '25 is ₹ 14.86 crore as compare to the Sep '25 ebitda of ₹ 109.53 crore. This represent the decline of -86.43% The net profit of FDC Ltd changed from ₹ 119.04 crore to ₹ 28.3 crore over 7 quarters. This represents a CAGR of -56.00% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -5.55 crore to ₹ -88.7 crore over 7 quarters. This represents a CAGR of 387.29% The Dividend Payout of FDC Ltd changed from 29.75 % on March 2025 to 29.75 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About FDC Ltd

FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About OneSource Specialty Pharma Ltd

Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

FAQs for the comparison of FDC Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, FDC Ltd or OneSource Specialty Pharma Ltd?

Market cap of FDC Ltd is 5,937 Cr while Market cap of OneSource Specialty Pharma Ltd is 19,938 Cr

What are the key factors driving the stock performance of FDC Ltd and OneSource Specialty Pharma Ltd?

The stock performance of FDC Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and OneSource Specialty Pharma Ltd?

As of May 3, 2026, the FDC Ltd stock price is INR ₹364.7. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹1739.2.

How do dividend payouts of FDC Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of FDC Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.